Prospective evaluation of pelvic lymph node staging with 18fluorine prostate-specific membrane antigen PET/CT prior to extended lymph node dissection in primary prostate cancer – t... by B.H.E. Jansen, Y.J.L. Bodar, G.J.C. Zwezerijnen, J.A. Nieuwenhuijzen, M. Wondergem, T. Roeleveld, O.S. Hoektra, J. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis

Get full text

Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies. The SESAME-study by Y.J.L. Bodar, B.P.F. Koene, D. Meijer, P.J. Van Leeuwen, J.A. Nieuwenhuijzen, R.J.A. Van Moorselaar, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis

Get full text

Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: Tumor localizations using PSMA PET/CT imaging by D. Meijer, M.L. Donswijk, Y.J.L. Bodar, P.J. Van Leeuwen, H.G. Van Der Poel, W.V. Vogel, J.A. Nieuwenhuijzen, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis

Get full text

Detection of intraprostatic tumor localisation with 18-Fluorine Prostate-Specific Membrane Antigen (PSMA) PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biops... by Y.J.L. Bodar, B.H.E. Jansen, P.J. Van Der Voorn, G.J.C. Zwezerijnen, J.A. Nieuwenhuijzen, N.H. Hendrikse, R.J.A. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis

Get full text

Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection by D. Meijer, H. De Barros, Y.J.L. Bodar, P.J. Van Leeuwen, B.H.E. Jansen, T.M. Van Der Sluis, H.G. Van Der Poel, J.A. Nieuwenhuijzen, D.E. Oprea-Lager, A.N. Vis

Get full text